Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬

Academic Medical Oncologist, senior clinical program leader, Immuno-oncology, Boehringer-Ingelheim, adjunct assistant professor, Georgetown University

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

@openart_ai I have send you multiple messages regarding fraudulent activity from somebody using your service. And nobody has responded to my emails and messages. Somebody has stolen my credit card and is using to create accounts in your website. You are responsible for any illegal activity

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

@openart_ai I have send you multiple messages regarding fraudulent activity from somebody using your service. And nobody has responded to my emails and messages. Somebody has stolen my credit card and is using to create accounts in your website. You are responsible for any illegal activity

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Complete response in a melanoma by our Boehringer Ingelheim STING agonist in combination with immunotherapy, presented at 2025 ESMO

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Exciting data of new immune checkpoint inhibitors targeting immune cold tumors at ESMO

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Boehringer meeting before 2025 ESMO. Unprecented aldata and vision to help our patients to fight cancer ! Inspired to be part of Boehringer-Ingelheim

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Exciting updates at the Boehringer Ingelheim meeting at ASCO 2025

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Exciting updates at the Boehringer Ingelheim meeting at ASCO 2025

[Cancer Cell @Cancer_Cell]

Online Now: Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells https://t.co/c7UE3PwKzA

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

@chulkimMD @StephenVLiu @Joshua_Reuss Have fun!!

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

A great talk by Dr Al-Refaie in our Gastric and Soft Tissue Neoplasms meeting today sponsored by Georgetown Lombardi !! An elegant talk

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

An elegant presentation by Dr Smith in our Gastric and Soft Tissue Neoplasms meeting today sponsored by Georgetown Lombardi !!

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

A great talk about Dr Al-Refaie in our Gastric and Soft Tissue Neoplasms meeting today sponsored by Georgetown Lombardi !! An elegant talk

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Our 10th “Gastric and Soft Tissue Neoplasms 2023” is launching today. Very exciting !

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Our 10th “Gastric and Soft Tissue Neoplasms 2023” is launching today. Very exciting !

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

@StephenVLiu You should try some Venice recipes in Italy with nera sepia a polenta :)

[BellRinger @RideBellRinger]

Waving hello to the weekend! #GearUpEndCancer

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

Our new paper is online https://t.co/K669kkYvar @LombardiCancer @MedStarGUH

[Sosipatros Alexander Boikos MD 🇬🇷 🌻 ⛵ 🔬 @SABOIKOS_MD]

@jamecancerdoc @caseccc @ClevelandClinic @UHhospitals @cwru Congratulations. A great leader in a great environment!!

[Jame Abraham, MD, FACP @jamecancerdoc]

We are excited to welcome Dr. Gary Schwartz to @caseccc @ClevelandClinic @UHhospitals @cwru #Cleveland !!

[Jim Hughes @TJH43]

Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations | npj Precision Oncology https://t.co/Z8LRSp5UAJ